Navigation Links
Is There Any Clinical Benefit to Staying on a Failing Regimen?

protease inhibitors and ritonavir-boosted protease inhibitors. 43% of patients were receiving two nucleoside analogues and a single protease inhibitor, while 39% were receiving a regimen containing drugs from all three classes.

One genotypic resistance test was used to define the baseline resistance pattern in 75 patients; two genotypic tests defined resistance in 23, and three tests defined resistance in the remaining 12 patients. Thymidine analogue mutations (TAMS) accounted for 75% of all DRGs and the mutation was primarily at the 184V codon. The evolution of resistance was then evaluated between the baseline test (t0) and a subsequent test a median of six months later (t1) (range 2-28 months).

From the time of the first genotypic test to the second, 77% of patients acquired one or more extra International AIDS Society (IAS)-defined drug resistance mutations, with an overall six month increase of 1.96 mutations. Using the Rega interpretation system, this meant an overall average loss of 1.25 active antiretroviral drugs per each six-month period that a patient remained on a failing regimen (this includes all ARVs available in January 2006). The authors note though that depending on the drug regimen followed and the extent of resistance, it cannot be assumed that the accumulation of mutations is limitless.

In this same time period, the mean CD4 cell count remained relatively stable at ~280 cells/mm3 with an estimated loss of 9.79 cells/mm3 while viral load rose by approximately 0.14 log10 copies/mL, resulting in a mean viral load of 3.87 log10 copies/mL.

The prevalence of resistance to the failing regimen at the time of the first resistance test was not predictive of the accumulation of drug resistance mutations when an adjusted analysis was performed. The main predictor of change in the number of IAS-defined mutations over time was an inverse association with CD4 cell count nadir. Those patients in the cohort with re
'"/>




Page: 1 2 3

Related medicine news :

1. Could There Be A Link Between Famine and Breast Cancer ?
2. Can There Be A Diabetes Type III?
3. Diabetic Amputation May Reduce If Free Screenings Are There
4. Hospital Says There Is Time but Baby Decides Otherwise
5. WHO’s asking :Is There Light At The End Of The Tunnel In Tajikistan
6. There is light at the end of the blind tunnel: prosthetic retinal cells offer hope!
7. Is There A Strong Link Between Fluoride In Tap Water And Bone Cancer?
8. Is There a Connection between Hearing loss and High-speed Dental Tools?
9. Clinical trials need to be more frank
10. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
11. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: There Any Clinical Benefit Staying Failing Regimen

(Date:9/2/2015)... ... September 02, 2015 , ... Available in select spas ... PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution of the classic ... with a lipid-replenishing marine oil for intense nourishing and moisturizing. Phytomer exclusive ingredient ...
(Date:9/2/2015)... ... 02, 2015 , ... Canopy Partners, a North Carolina based ... 5000 List, an independent ranking of the fastest- growing private companies in ... achievement puts Canopy in rarefied company. Over the years, this elite group has ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an ... flora and fauna. , Lifestyle Holidays Vacation Club knows that Puerto ... travelers experience that much better, Lifestyle Holidays Vacation Club has put together its list ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... September is ... this disease that affects more than 233,000 men each year in the United States. ... the most common non-skin cancer in America, affecting 1 in 7 men. One new ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
Breaking Medicine News(10 mins):Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3
... 12, 2011Michael L. Dennis, Ph.D., Senior Research Psychologist ... Christy K. Scott, Ph.D., Research Psychologist at the ... Anderson Research Award for their long-term outcomes study ... treatment outcomes among adults attending alcohol/drug treatment. Sponsored ...
... Public Images: Cut and paste into the body of ... search to date of DNA abnormalities in chronic lymphocytic ... drive this common blood cancer, a finding that could ... will progress rapidly or remain indolent for years, say ...
... Medical researchers at the University of Alberta have created ... and informational topics related to weight, that parents can ... child,s weight management with health professionals. Researchers in ... of Alberta created these ,conversation cards, based on their ...
... multiforme (GBM) is the most common and lethal of ... For most patients, treatment involves surgery followed by both ... are resistant to the effects of temozolomide. A team ... of Toronto, Toronto, has now determined that the protein ...
... brain atrophy patterns in Alzheimer,s disease patients using MRIs ... to a new study by researchers from the Perelman ... also found that higher baseline Alzheimer,s patterns of atrophy ... The study is published online in Brain . ...
... be part of the Homo erectus diet. But the ... survival of Homo erectus and the evolution of modern ... Tel Aviv University researchers Dr. Ran Barkai, Miki Ben-Dor, and Prof. ... Studies examined the published data describing animal bones associated with ...
Cached Medicine News:Health News:Drs. Michael Dennis and Christy Scott earn Hazelden’s Dan Anderson Research Award 2Health News:Drs. Michael Dennis and Christy Scott earn Hazelden’s Dan Anderson Research Award 3Health News:Massive DNA search uncovers new mutations driving blood cancer 2Health News:Massive DNA search uncovers new mutations driving blood cancer 3Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 2Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 3Health News:Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease 2Health News:The disappearance of the elephant caused the rise of modern man 2Health News:The disappearance of the elephant caused the rise of modern man 3
(Date:9/1/2015)... SPRINGDALE, Ark. , Sept. 1, 2015 NOWDiagnostics Inc., ... completed its acquisition of ZBx Corporation of Canada ... to its vision of a world where people have ... NOWDiagnostics manufactures and sells a line of unique blood-based ... simple-to-use, highly accurate tests for a variety of ailments ...
(Date:9/1/2015)... , Sept. 1, 2015 UT Southwestern ... and distinguished faculty members joined U.S. Representatives Michael ... in a roundtable discussion on the 21 st ... research currently being considered by the United ... – including National Academy of Sciences members, department chairs, ...
(Date:9/1/2015)... RIDGEFIELD, Conn. , Sept. 1, 2015  Results ... RE-VERSE AD™ study demonstrate that 5g of idarucizumab ... urgent situations involving patients treated with dabigatran (Pradaxa ... reversal of the anticoagulant effect of dabigatran enabled ... with a median time of 1.7 hours between ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9
... Calif., Oct. 27 STAAR Surgical Company (Nasdaq: STAA ) today ... September 30, 2009 on Monday, November 2, 2009 ... host a conference call and webcast on Tuesday, November 3, ... Pacific to discuss the Company,s third quarter results and current ...
... 27 CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), ... segment of the In-Vitro Diagnostic (IVD) testing market, has ... the letter in its entirety, please visit the following ... , In the letter, CardioGenics Chief Executive Officer, ...
Cached Medicine Technology:STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call 2CardioGenics Holdings Inc. Announces Letter to Shareholders 2CardioGenics Holdings Inc. Announces Letter to Shareholders 3
... to dilate the lower ureter ... assess possible submucosal tunneling. Also ... anesthetic in the ureter. The ... or dislodgment of a ureteral ...
... Used for the injection of contrast medium, ... dual lumen design eliminates the need for ... to promote atraumatic passage into and through ... of hydrophilic polymer that when activated, attracts ...
Used for retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Medicine Products: